Mean serum penicillin G levels and 95% confidence intervals for days since injection.

<p>Mean serum penicillin G levels and 95% confidence intervals for days since injection.</p

Mean BPG level and 95% confidence interval versus day since injection.

<p>Each subject provided a sample 1 day after injection and two more over the course of 28 days. The serum penicillin G half life is 4.1 days. At approximately day 11 the expected mean penicillin G serum level is less than 0.02 µg/ml. On days 1, 2 and 3 the 95% confidence intervals extend upward beyond 0.13 and are truncated to allow more visual resolution at the lower end of the curve. (Note: day 21 outlier removed from calculation of mean; see text.).</p

Percentage of subjects whose penicillin G serum level was greater than three proposed minimum protective versus day since injection.

<p>Logarithmic trend-line estimates are shown for each protection level. As days progress, the percentage of values above minimum protective per day continually decreases with some day-to-day variation. (Note:day 21 outlier removed from calculation of percentages; see text.)</p

Demographics of study subjects.

<p>Demographics of study subjects.</p

Plan for blood draws.

<p>Each cohort had 10 groups, and each group had between 12 and 18 subjects.</p

Number of published evaluations and variables on identified EEBS’s.

<p>*Not all EEBS’s were operational at the time of this report. URL provided when one could be identified.</p><p>Number of published evaluations and variables on identified EEBS’s.</p

Assessment of variables across EEBS evaluations.

<p>Assessment of variables across EEBS evaluations.</p

Crude and Adjusted OR for Hospitalized and Non-hospitalized Cases and Controls.

<p>Note: OR = Odds Ratio.</p><p>*Adjusted for sex, age group, and number of prior vaccinations.</p

Correlations between <i>emm</i> groups and <i>emm</i> types.

<p><i>emm</i> types (identified by <i>emm</i> gene sequence analysis) associated with each <i>emm</i> group (set of equally likely <i>emm</i> types, as identified by T-5000 PCR/ESI-MS analysis); Contradictory identifications are shown in bold. All identities are shown as “identity (number identified)” for that specific associative category.</p

Influenza Vaccine Effectiveness by Influenza Subtype: Comparison to Matched Healthy Controls.

*<p>Influenza subtype data only available for USAFSAM cases. Due to small sample size, adjusted estimates not available.</p